REDWOOD CITY, Calif., May 5, 2015 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced that management will present at two investor conferences in May:

  • Senior Vice President and CFO Gordon Sangster will present at the 16th Annual B. Riley & Company Investor Conference on Tuesday, May 12, 2015, at 8:30 a.m. Pacific Time (11:30 a.m. Eastern Time). The conference is being held at the Loews Hollywood Hotel in Los Angeles. A live webcast and replay of the presentation will be available on the Investors section of the company's website, http://ir.codexis.com/.
     
  • President and CEO John Nicols and Mr. Sangster will be attending the Craig-Hallum 12th Annual Institutional Investor Conference on Wednesday, May 27, 2015, at the Depot Renaissance Minneapolis Hotel in Minneapolis.

About Codexis, Inc.

Codexis, Inc. is a leading protein engineering company that applies its technology to the development of biocatalysts for the commercial manufacture of pharmaceuticals and fine chemicals. Codexis' proven technology enables implementation of biocatalytic solutions to meet customer needs for rapid, cost-effective and sustainable manufacturing. For more information, see www.codexis.com.

CONTACT:     Investors
                       LHA
                      Jody Cain, 310 691 7100
                      jcain@lhai.com

                      Media
                       Notch Communications
                      Kate Whelan, +46 (0)70 238 11 49
                      Kate.whelan@notchcommunications.co.uk

CDXS LOGO